258 filings
Page 5 of 13
S-8
8wvz9
29 Jan 21
Registration of securities for employees
4:01pm
8-K
oyd03m606hpb 5z
27 Jan 21
Other Events
7:00am
8-K
puyilcjzsjv8
7 Dec 20
Other Events
8:00am
8-K
ohdwu awgs
2 Dec 20
Other Events
7:00am
8-K
5jkixtgbdwtj
5 Nov 20
GBT Reports Recent Business Progress and Third Quarter 2020 Financial Results
4:06pm
8-K
9qucpu0ndmtz
4 Nov 20
GBT Announces Upcoming Virtual Data Presentations at 62nd American Society of Hematology (ASH) Annual Meeting & Exposition
3:16pm
8-K
ez7p2mtfr yd28
26 Oct 20
GBT Presents Data at 15th Annual Scientific Conference on Sickle Cell and Thalassemia
7:48am
S-8
23rnyoc 6q
7 Aug 20
Registration of securities for employees
4:25pm
S-3ASR
076u33
5 Aug 20
Automatic shelf registration
5:25pm
8-K
90yjllu7iojmo7
5 Aug 20
GBT Reports Recent Business Progress and Second Quarter 2020 Financial Results
4:01pm
8-K
8zt6jrp2uz nvrd0
24 Jun 20
GBT Announces Plans to Seek Regulatory Approval for Oxbryta® (voxelotor) to Treat Sickle Cell Patients in Europe
8:30am
8-K
01oe b5r5
19 Jun 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
acab5g
8 Jun 20
GBT Announces Plans to Seek Expanded Labeling for Oxbryta® (voxelotor) to Treat Children Ages 4 to 11 Years with Sickle Cell Disease
4:05pm
8-K
5qbwrxhof2dne7z3u
1 Jun 20
Departure of Directors or Certain Officers
4:15pm
8-K
v2t6ig3n
15 May 20
Departure of Directors or Certain Officers
12:00am
8-K
v1xx0a1j1wna100e
6 May 20
GBT Reports Recent Business Progress and First Quarter 2020 Financial Results
4:05pm
DEFA14A
n0znqthpl mb8p
28 Apr 20
Additional proxy soliciting materials
4:03pm